UNITY BIOTECHNOLOGY INC - COM (UBX)

CUSIP: 91381U101

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class
Equity / COM
Total 13F shares
16,032,304
Share change
-2,180,248
Total reported value
$74,381,136
Put/Call ratio
112%
Price per share
$4.64
Number of holders
86
Value change
-$10,924,996
Number of buys
42
Number of sells
44

Quarterly Holders Quick Answers

What is CUSIP 91381U101?
CUSIP 91381U101 identifies UBX - UNITY BIOTECHNOLOGY INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of UNITY BIOTECHNOLOGY INC - COM (UBX) as of Q2 2021

As of 30 Jun 2021, UNITY BIOTECHNOLOGY INC - COM (UBX) was held by 86 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 16,032,304 shares. The largest 10 holders included FMR LLC, BAILLIE GIFFORD & CO, VANGUARD GROUP INC, Invus Financial Advisors, LLC, MORGAN STANLEY, BlackRock Inc., JACOBS LEVY EQUITY MANAGEMENT, INC, MILLENNIUM MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 86 institutional shareholders reporting positions in this security for the Q2 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.